• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Life-Sciences-France.com
The French Life Sciences Web Portal

This is a free web portal for the life sciences in France and Monaco... » read more

• French Biotech Start-Up Seekyo Raises €800k in Equity/Loans (2020-01-20)
  The funds will allow the company to accelerate the development of its chemotherapy drug candidate targeting solid tumors Seekyo, a privately-owned biotech start-up specializing in the development of the next generation of chemotherapies, announces today that i...
• Rafaèle Tordjman Launches Jeito Capital, Raises €200m (2020-01-15)
  Rafaèle Tordjman launches JEITO CAPITAL, a new French and independent investment investor dedicated to biotech and biopharma. The launch is completed by the closing of JEITO I fund's with the support and investment of renowned institutional investors and family off...
• Urania Therapeutics Gets €1.7m Funding from Bpifrance (2020-01-14)
  Funding will support the development of its ‘readthrough’ drug candidates Urania Therapeutics announces today that it will benefit from €1.7 million ($1.9M) Deeptech financing from Bpifrance in addition to its recent seed funding round. The Deeptech plan, init...
• Waters to Acquire Andrew Alliance (2020-01-13)
  Waters enables core product portfolio with next-generation automation technology Waters Corporation (NYSE:WAT) announced today that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technolog...
• Domain Therapeutics Secures €6m Debt Financing (2020-01-13)
  GPCR company will expand proprietary portfolio and prepare next financing round Domain Therapeutics, a biopharmaceutical company specialized in the discovery and development of new drug candidates targeting G Protein-Coupled Receptors (GPCR) in neurology, o...
• Iovance Licenses TALEN Technology from Cellectis (2020-01-12)
  Iovance Biotherapeutics Will Use TALEN® Technology from Cellectis to Develop Gene-Edited TIL Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, and Cellectis (Euronext Growt...
• Alderaan Biotechnology: €18.5m Series A from AFB & Medicxi (2020-01-09)
  Funding will help develop technologies to deplete Treg cells in cancer and boost NK cell cytotoxic activity Alderaan Biotechnology, a preclinical stage company focused on monoclonal antibodies development for the treatment of cancer, announces today the succes...
• Nurix & Sanofi Partner for Protein Degradation Therapies (2020-01-09)
  Nurix Therapeutics, Inc., a company researching novel therapies that control degradation of disease-causing proteins, today announced a global strategic collaboration with Sanofi to discover, develop and commercialize a pipeline of innovative targeted protein degra...
• Debiopharm Leads Series A of Novadiscovery with €5m (2020-01-09)
  > Novadiscovery pioneers the use of in silico clinical trials to predict drug efficacy and optimize clinical development, an approach meeting the strong expectations from pharmaceutical companies for faster and more efficient development, and benefiting from increa...
• Grey Wolf Completes £2.5m Series A2 Financing (2020-01-09)
  Grey Wolf targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumors for attack and destruction by the immune system Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therap...

Life-Sciences-France.com is your doorway to the French life sciences!

[LSF] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations


in France and Monaco.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSF] is 100% Made in Germany!

Start here with the latest News!

Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.